2021
DOI: 10.3390/ijerph182312355
|View full text |Cite
|
Sign up to set email alerts
|

Development and Validation of a Machine Learning Model Predicting Arteriovenous Fistula Failure in a Large Network of Dialysis Clinics

Abstract: Background: Vascular access surveillance of dialysis patients is a challenging task for clinicians. We derived and validated an arteriovenous fistula failure model (AVF-FM) based on machine learning. Methods: The AVF-FM is an XG-Boost algorithm aimed at predicting AVF failure within three months among in-centre dialysis patients. The model was trained in the derivation set (70% of initial cohort) by exploiting the information routinely collected in the Nephrocare European Clinical Database (EuCliD®). Model per… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

0
5
0

Year Published

2022
2022
2024
2024

Publication Types

Select...
8
1
1

Relationship

1
9

Authors

Journals

citations
Cited by 17 publications
(5 citation statements)
references
References 39 publications
0
5
0
Order By: Relevance
“…Grace Fet, et al constructed an automated lung ultrasound image assessment using artifcial intelligence to identify uid overload in dialysis patients [50] , in order to provide a scienti c support for clinicians evaluating the liquid load of hemodialysis patients, so that they can help patients achieve higher dialysis quality. Ricardo Peralta, et al [51] established a machine learning model predicting arteriovenous stula failure, which had the ability to help vascular access doctors predict the rate of hemodialysis patients encountering with arteriovenous stula failure in early stage, as a result they could conduct an alternative plan in advance to solve the problem of vascular access of patients. However, there was no researches predicting the mortality risk of HIV/AIDS patients undergoing hemodialysis at present, and all the studies currently only focused on the mortality risk of HIV/AIDS patients [24] and hemodialysis patients [25] , the clinical application value of which were limited.…”
Section: Discussionmentioning
confidence: 99%
“…Grace Fet, et al constructed an automated lung ultrasound image assessment using artifcial intelligence to identify uid overload in dialysis patients [50] , in order to provide a scienti c support for clinicians evaluating the liquid load of hemodialysis patients, so that they can help patients achieve higher dialysis quality. Ricardo Peralta, et al [51] established a machine learning model predicting arteriovenous stula failure, which had the ability to help vascular access doctors predict the rate of hemodialysis patients encountering with arteriovenous stula failure in early stage, as a result they could conduct an alternative plan in advance to solve the problem of vascular access of patients. However, there was no researches predicting the mortality risk of HIV/AIDS patients undergoing hemodialysis at present, and all the studies currently only focused on the mortality risk of HIV/AIDS patients [24] and hemodialysis patients [25] , the clinical application value of which were limited.…”
Section: Discussionmentioning
confidence: 99%
“…However, in contrast to the present study, their model was limited to radio-cephalic AVFs only. Finally, Peralta et al 26 apply ML for predicting AVF failure within 3 months, based on routinely recorded clinical information of HD patients. Their work, which would enable risk-based personalization of AVF surveillance strategies, is therefore complementary to ours, which aims to support VA surgical planning.…”
Section: Discussionmentioning
confidence: 99%
“…Use of ACM has been shown to strongly improve hemoglobin target achievement and reduce drug utilization by 25% to 50% [ 27 , 29 ]. New AI modules, such as the Cardiovascular Literature-Based Risk Algorithm (CALIBRA [ 44 ]), the Prognostic Reasoning System for CKD Progression (PROGRES-CKD [ 45 ]) and the Arteriovenous Fistula Failure model (FFM [ 46 ]) to name a few, have been more recently developed using EuCliD data and are currently under evaluation before further clinical implementation.…”
Section: Euclid ® the European Clinical Databasementioning
confidence: 99%